Healthcare
from24/7 Wall St.
2 days agoNovo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low
Novo Nordisk's stock dropped 22% weekly and 56% yearly after CagriSema trial failure and announced price cuts on flagship drugs, causing analyst downgrades and declining Reddit sentiment.